KVD900, An Oral On-demand Treatment for Hereditary Angioedema; Phase 1 Study Results

About

Management team

Board of Directors

Science

Pipeline

Sebetralstat

Oral Factor XIIa Inhibitor

Careers

Job Openings

Contact

KalVista Terms of Use Privacy Policy
© 2025 KalVista Pharmaceuticals. All Rights Reserved.